Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Assessment of the toxicokinetic behaviour of the substance from the relevant available information was performed.
The evaluation of toxicokinetics is based on information from three sources:
- Experimental data of toxicological tests
- Literature data obtained from internet
- Data from toxicological databases – free and commercial

Key value for chemical safety assessment

Additional information

Overall low acute oral toxicity of Centralit was found, but the absorption to the mammalian body occurs. At lethal doses the Central nervous system disturbances, tremors, lethargy, tonic convulsions were seen. There are marked differences in toxicity between sexes, the males are much more resistant and they stand alive at doses which are distinctly lethal to females. If it could be by caused by differences in absorption is unknown.

Sex differences in susceptibility to toxic effects of Centralite were noted also in studies with repeated administration. In these the effect on neural system of animals is manifested as Straub phenomenon in first days of administration. This reaction is similar for animals after application of opiate substance, e.g. morphine. During next weeks of study, these changes were not observed any more, which can relate with adaptation of organism of treated animals to the test substance. Everything written above reads for females. In males no such distinct reaction was observed. But in both sexes the effect on liver weight and function, changes in some blood parameters and plasma enzymes were noted.

Administration of Centralit had no adverse effect to ability of male and female animals to successfully mate and produce viable offspring. No signs of any gonadotropic or mutagenic effects were found.


Finally it could be concluded that Centralit after oral administration is absorbed into body of animals, metabolized in liver and either per se or as metabolites is rapidly distributed to CNS. It is questionable if it could reach also the reproduction organs.

The absorption through skin or eye mucosa is much less probable. Respiratory tract absorption could occur but the efficiency of this process is not known.

No information was found about the metabolism and elimination of Centralit.